IL36237A - Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL36237A
IL36237A IL36237A IL3623771A IL36237A IL 36237 A IL36237 A IL 36237A IL 36237 A IL36237 A IL 36237A IL 3623771 A IL3623771 A IL 3623771A IL 36237 A IL36237 A IL 36237A
Authority
IL
Israel
Prior art keywords
methoxy
benzyl
ethoxy
imidazolidinone
hydroxy
Prior art date
Application number
IL36237A
Other languages
English (en)
Other versions
IL36237A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL36237A0 publication Critical patent/IL36237A0/xx
Publication of IL36237A publication Critical patent/IL36237A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL36237A 1970-02-24 1971-02-19 Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them IL36237A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1376970A 1970-02-24 1970-02-24

Publications (2)

Publication Number Publication Date
IL36237A0 IL36237A0 (en) 1971-04-28
IL36237A true IL36237A (en) 1974-11-29

Family

ID=21761656

Family Applications (1)

Application Number Title Priority Date Filing Date
IL36237A IL36237A (en) 1970-02-24 1971-02-19 Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US3636039A (da)
JP (1) JPS5421338B1 (da)
BE (1) BE763298A (da)
BR (1) BR7101125D0 (da)
CA (1) CA967163A (da)
CH (2) CH567482A5 (da)
DE (1) DE2108438C2 (da)
DK (2) DK134601B (da)
FI (1) FI54919C (da)
FR (1) FR2081537B1 (da)
GB (1) GB1292768A (da)
IE (1) IE35283B1 (da)
IL (1) IL36237A (da)
NL (1) NL171446C (da)
NO (1) NO130680C (da)
SE (1) SE369190B (da)
YU (1) YU34407B (da)
ZA (1) ZA711077B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones
US3966758A (en) * 1975-06-16 1976-06-29 Morton-Norwich Products, Inc. Anti-inflammatory 1-(substituted benzyl)-2-imidazolidinones
US4063022A (en) * 1976-11-22 1977-12-13 Morton-Norwich Products, Inc. Antisecretory 2-imidazolidinones
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
CA1188616A (en) * 1981-06-11 1985-06-11 Hoffmann-La Roche Limited Pharmaceutical preparations
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
AU4527996A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
CA2920856A1 (en) 2013-08-09 2015-02-12 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518285A (de) * 1968-05-01 1972-01-31 Hoffmann La Roche Verfahren zur Herstellung von neuen substituierten Benzylimidazolidinonen

Also Published As

Publication number Publication date
GB1292768A (en) 1972-10-11
BE763298A (fr) 1971-08-23
DE2108438C2 (de) 1987-02-05
NL171446C (nl) 1983-04-05
FI54919C (fi) 1979-04-10
CA967163A (en) 1975-05-06
DK134601B (da) 1976-12-06
IE35283L (en) 1971-08-24
FR2081537A1 (da) 1971-12-03
DK570075A (da) 1975-12-15
NO130680C (da) 1975-01-22
FR2081537B1 (da) 1974-08-23
DE2108438A1 (de) 1971-09-09
US3636039A (en) 1972-01-18
YU43971A (en) 1978-12-31
JPS5421338B1 (da) 1979-07-30
NL171446B (nl) 1982-11-01
NL7102324A (da) 1971-08-26
IL36237A0 (en) 1971-04-28
YU34407B (en) 1979-07-10
FI54919B (fi) 1978-12-29
NO130680B (da) 1974-10-14
SE369190B (da) 1974-08-12
DK134601C (da) 1977-05-16
ZA711077B (en) 1971-10-27
IE35283B1 (en) 1976-01-07
CH567483A5 (da) 1975-10-15
CH567482A5 (da) 1975-10-15
BR7101125D0 (pt) 1973-04-26

Similar Documents

Publication Publication Date Title
IL36237A (en) Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them
US4182767A (en) Antihyperglycemic N-alkyl-3,4,5-trihydroxy-2-piperidine methanol
US4207324A (en) 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use
RU2213743C2 (ru) Производное тиенилазолилалкоксиэтанамина, способ его получения (варианты), фармацевтическая композиция, промежуточный продукт и способ его получения (варианты)
US4423044A (en) 3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use thereof
JP2637737B2 (ja) 新規な薬剤
NZ212856A (en) Glutarimide derivatives and pharmaceutical compositions
US3923833A (en) N-{8 (1-cyano-2-phenyl)ethyl{9 carbamates
US3536713A (en) N-(hydroxy-cyclohexyl)-aminobenzylamines and the salts thereof
NO135140B (da)
US3804899A (en) 3-alkylamino-2-(3,4-dihydroxyphenyl)propanols and the salts thereof
US3892777A (en) Substituted benzylethylenedicarbamates
US3592824A (en) 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
SE409700B (sv) Forfarande for framstellning av nya amino-fenyl-etanolaminer och deras oxazolidiner
EP0009800A2 (en) 4-Phenyl-1,3-benzodiazepines, method for their preparation, pharmaceutical compositions containing them, and the compounds for use as medicaments
US3591636A (en) Substituted benzylideneamino guanidines
US6075018A (en) 1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine derivatives
US3459767A (en) Aminomethylindoles
US3972935A (en) Antiarrhythmic agents
US3997608A (en) N-substituted-dihydroxyphenethylamines
US3905990A (en) Basically substituted benzimidazole derivatives
JPS60132962A (ja) Ｎ−置換イソキノリン誘導体
US3957785A (en) Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
US3775479A (en) Amine compounds
US3943173A (en) 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols